ONCAlert | Upfront Therapy for mRCC

Immunotherapy VIEW MORE >>

In an interview with Targeted Oncology, Benjamin Besse, MD, PhD, discussed the research around the Tedopi vaccine and how it addresses an unmet medical need for the treatment of patients with non-small cell lung cancer who have failed immune checkpoint inhibitors. He also explained the use of genomic testing to aid the treatment of non-small cell lung cancer.

Latest JournalAll Journals >>

Copyright © TargetedOnc 2020 Intellisphere, LLC. All Rights Reserved.